Effect of Codonopsis lanceolata Extract on Blood Pressure in Pre-hypertensive Adults

Effect of Codonopsis lanceolata Extract on Blood Pressure, Blood Lipid and Oxidative Stress in Pre-hypertensive Adults

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CRIS

Registry ID

KCT0003735

Enrollment

Registered

2019-04-10

Start date

2018-09-01

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The experimentaty group was received CL capsules (CL extract 500 mg/capsule) and placebo group was received control capsules (CL extract 0 mg/capsule). The subjects take 2 capsule

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pre-hypertensive phase (systolic blood pressure: 120-139 mmHg or diastolic blood pressure: 80-89 mmHg) 2) Those who are in a state of consciousness and able to communicate 3) Those who have taken CL, but do not have allergic reaction 4) Who is not allergic to corn starch

Exclusion criteria

Exclusion criteria: 1) Those who have been administered other clinical trial drugs for the previous 3 months or participated in other clinical trials 2) Those with hypertensive diseases requiring medical treatment 3) Those taking blood pressure medicine 4) People with kidney disease and diabetic drug 5) Pregnant women, newborns, minors and research institutes employees 6) Those who are admitted to collective facilities, homeless, unemployed, poverty, bum, refugees, minority race 7) Patients with terminal illness or emergency situations

Design outcomes

Primary

Measure	Time frame
blood pressure	—

Secondary

Measure	Time frame
serum lipids;oxidative stress	—

Countries

Korea, Republic of

Contacts

Public ContactA YOUNG HAN

Korea University

hanayoung2963@gmail.com+82-2-3290-4905

Outcome results